Schedule 13G ownership disclosure

Collegium Pharmaceutical Inc

Security class unavailable · CUSIP: 19459J104

Event date: 2022-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,987,495
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-22-000086
Form type
SC 13G/A
Filer
COLLEGIUM PHARMACEUTICAL, INC
CIK
CIK 1267565
Filed
Sep 09, 2022
Reporting period
Aug 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub